 ACADIA Pharmaceuticals, Inc. NASDAQ:ACAD Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Mark Johnson - VP, IR Stephen Davis - CEO Director Brendan Teehan - EVP, COO Head, Commercial Kathie Bishop - SVP and Head, Rare Disease External Innovation Srdjan Stankovic - President Mark Schneyer - EVP CFO Conference Call Participants Jeff Hung - Morgan Stanley Neena Bitritto-Garg - Citi Ritu Baral - Cowen and Company Salveen Richter - Goldman Sachs Jay Olson - Oppenheimer Alex Nackenoff - Raymond James Associates Marc Goodman - SVB Securities Gregory Renza - RBC Capital Markets Yatin Suneja - Guggenheim Securities Charles Duncan - Cantor Fitzgerald Sumant Kulkarni - Canaccord Genuity Operator Good day, ladies and gentlemen, and welcome to ACADIA Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. My name is Gigi, and I will be your coordinator for today. 